BRC News

A new hand-held scanner developed by UCL researchers and tested in a series of clinical trials at UCLH can generate highly detailed 3D images in just seconds.

UCLH is one of 13 NHS hospitals running a world-leading study in which hundreds of babies will be tested for over 200 rare genetic conditions.

Researchers have found that people who eat more ultra-processed foods (UPF) are at increased risk of developing type 2 diabetes, but this risk can be lowered.

More than 400 patients at UCLH have so far benefitted from the therapy, which uses high-energy beams of protons to deliver a dose of radiotherapy.

New devices such as cuff-less wrist monitors are likely to play an important role in hypertension in future but several challenges remain, according to a new paper.

Heatwaves can worsen abnormal excitability of the brain in people with epilepsy, finds a new small-scale patient study by clinical scientists at UCL.

A BRC team has identified the factors which predict full hearing recovery. The strongest predictor is treatment with steroids within seven days of a sudden drop in hearing.

A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.

A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.

The early phase trial is of a potential new medicine for patients that have a specific sub-type of multiple myeloma, a type of bone marrow cancer.

The UCLH BRC is to co-lead a data initiative to improve care for people with hearing loss.

The Summer 2024 edition of the UCLH Clinical Research Facility's early phase cancer trials newsletter is out now.

Public health interventions that tackle dementia risk factors could yield as much as £4bn in savings in England by reducing dementia rates and helping people to live longer and healthier.

A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections.

Do-it-yourself human papillomavirus tests could enable more than a million more women in England to participate in cervical screening over the next three years, according to a UCL-sponsored trial.